Therapeutic drug monitoring of systemic antifungal therapy

[Therapeutic drug monitoring of antifungal agents].

Antifungal therapeutic drug monitoring: established and emerging indications.

Andres Pascual Dept of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-1011 Lausanne, Switzerland [email protected] 41 21 314 0909 AC CE PT ED Copyright © 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. Antimicrob. Agents Chemother. doi:10.1128/AAC.00705-08 AAC Accepts, published online ahead of print on...

Antifungal therapeutic drug monitoring: when, how, and why.

In recent years, the incidence of invasive fungal infections (IFI) has risen in parallel with a growing population of patients immunosuppressed as a consequence of different conditions, such as HIV infection, increasingly aggressive surgical techniques, solid organ and hematopoietic transplantations, illness severity of critically ill patients and, in a lower rate, anti-TNF therapies.1–3 In spi...

A Review on Therapeutic Drug Monitoring of Immunosuppressant Drugs

Immunosuppressants require therapeutic drug monitoring because of their narrow therapeutic index and significant inter-individual variability in blood concentrations. This variability can be because of factors like drug-nutrient interactions, drug-disease interactions, renal-insufficiency, inflammation and infection, gender, age, polymorphism and liver mass. Drug monitoring is widely practiced ...

therapeutic drug monitoring

0